Ready To Launch But Nowhere To Go: Regeneron's Eylea Gets FDA Delay
The biotech says it is prepared to launch the wet-AMD drug immediately following FDA approval, which is now expected by Nov. 18.
The biotech says it is prepared to launch the wet-AMD drug immediately following FDA approval, which is now expected by Nov. 18.